Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus

Zelnick, J. R., Daftary, A., Hwang, C., Labar, A. S., Boodhram, R., Maharaj, B., Wolf, A. K., Mondal, S., Amico, K. R., Orrell, C., Seepamore, B., Friedland, G., Padayatchi, N., & O’Donnell, M. R. (2020). Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus. Clinical Infectious Diseases, 73(7), e1901–e1910. https://doi.org/10.1093/cid/ciaa1557
Authors:
Jennifer R Zelnick
Amrita Daftary
Christina Hwang
Amy S Labar
Resha Boodhram
Bhavna Maharaj
Allison K Wolf
Shinjini Mondal
K. Rivet Amico
Catherine Orrell
Boitumelo Seepamore
Gerald Friedland
Nesri Padayatchi
Max R O'Donnell
Affiliated Authors:
Christina Hwang
Amy S Labar
Allison K Wolf
Max R O'Donnell
Author Keywords:
person-centered care
drug-resistant tb/hiv
south africa
adherence
mixed-methods
Publication Type:
Article
Unique ID:
10.1093/cid/ciaa1557
PMID:
Publication Date:
Data Source:
Scopus

Record Created: